Source: International Congress 2017 – Therapeutic approaches in lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Wang (Taipei, Taiwan). TGF-ß1-Mediated CTGF Upregulation Through Transactivation of EGFR in Fibrocytes of Chronic Obstructive Asthma. 4917

Member's Comments

No comment yet.

Related content which might interest you: mTOR Pathway Activation Drives Lung-Cell Senescence and Emphysema in Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Expression and function of IL-20 cytokines and their receptors on the airway epithelium during Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Increased Exacerbations of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Carriers Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Serum Heparanase Levels are Associated with Endothelial Dysfuntion and Severity of Obstructive Sleep Apnea Syndrome Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017 Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 1999 Year: 1999 Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco as risk factor to cachexia. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Chronic Obstructive Pulmonary Disease Exacerbations Source: Eur Respir Rev 2009; 18: 305 Year: 2009 Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease Source: Guideline 2014 Year: 2014 Pathogenic bacteria for exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017